Spine

Here are eight things for spinal surgeons to know for Dec. 8, 2016.

A new study published in Spine compares posterolateral fusion with interbody fusion for patients with degenerative spondylolisthesis.

Chesterfield, U.K.-based Mallinckrodt Pharmaceuticals reported results from a study of the company's OFIRMEV (acetaminophen) injections. OFIRMEV is the only intravenous formulation of acetaminophen that is FDA approved and marketed in the United States. The study compared the use of oral…

An infant with spinal muscular atrophy type 1 became the first baby to receive an experimental drug, nusinersen, to treat her condition in 2013, according to Medical Xpress.

James Fish, DO, affiliated with The Hughston Clinic in Nashville, Tenn., performed Rutherford County's first two-level cervical disc replacement, according to WGNS News Radio.

Here are three spine surgeons and neurosurgeons who recently received awards or promotions.

A new study published in The Spine Journal examines the characteristics of patients reporting maximum pain on the visual analog scale.

A new study published in the Journal of Bone and Joint Surgery examined adolescent scoliosis patients who underwent treatment with the use of growing rods to determine whether their last planned fusion was actually the final fusion.

Here are seven key stories on outpatient spine trends and news:

The spinal muscular atrophy treatment market is expected grow between 2015 and 2021, based on a Persistence Market Research report, according to medGadget.